{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T21:50:58Z","timestamp":1724881858872},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T00:00:00Z","timestamp":1624665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T00:00:00Z","timestamp":1624665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Ductal carcinoma in situ (DCIS) patients are usually diagnosed through cancer screening programs, suggesting a healthy user effect. In this population-based cohort, we assessed the risk of cardiovascular events and mortality in DCIS patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Using the Korean National Health Insurance Service database, 13,740 women, who were initially diagnosed with DCIS between 2007 and 2013, were analyzed. A control group was matched according to age and the year of diagnosis at a 3:1 ratio (<jats:italic>n<\/jats:italic>\u00a0=\u200941,220). Follow-up was performed until 2016. Subgroup analysis was performed according to the subsequent diagnosis of invasive breast cancer within 1\u2009year: pure DCIS and DCIS+Invasive group.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>DCIS patients were more likely to have underlying diseases, higher incomes, and to live in urban districts compared to the control group. Women diagnosed of DCIS had lower myocardial infarct risk (hazard ratio [HR] 0.64; 95% confidence interval [CI] 0.46\u20130.90) and lower stroke risk (HR 0.77; 95% CI 0.60\u20130.98) compared to the control group. This trend of lower risk was sustained after adjusting for age, income, residence and comorbidities. The mortality rate was similar between the control group and pure DCIS patients but was higher in the DCIS+Invasive group (HR 1.63; 95% CI 1.34\u20131.98). However, after adjusting for age, income, residence and comorbidities, mortality did not differ between the control group and DCIS+Invasive group (HR 0.99; 95% CI 0.78\u20131.24).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>DCIS patients were at lower risk for MI and stroke compared to a control group despite a higher rate of comorbidities, which may reflect changes in health behaviour. The importance of managing pre-existing comorbidities along with DCIS treatment should be emphasized.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12885-021-08494-0","type":"journal-article","created":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T20:03:24Z","timestamp":1624737804000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Cardiovascular events and mortality in a population-based cohort initially diagnosed with ductal carcinoma in situ"],"prefix":"10.1186","volume":"21","author":[{"given":"Tae-Kyung","family":"Yoo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Hyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung","family":"Do Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byung Joo","family":"Chae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,26]]},"reference":[{"issue":"4","key":"8494_CR1","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1158\/1055-9965.EPI-04-0849","volume":"14","author":"CI Li","year":"2005","unstructured":"Li CI, Daling JR, Malone KE. Age-specific incidence rates of in situ breast carcinomas by histologic type, 1980 to 2001. Cancer Epidemiol Biomark Prev. 2005;14(4):1008\u201311. https:\/\/doi.org\/10.1158\/1055-9965.EPI-04-0849.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"5","key":"8494_CR2","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.breast.2012.01.014","volume":"21","author":"M Puig-Vives","year":"2012","unstructured":"Puig-Vives M, Pollan M, Rue M, Osca-Gelis G, Saez M, Izquierdo A, et al. Rapid increase in incidence of breast ductal carcinoma in situ in Girona, Spain 1983-2007. Breast. 2012;21(5):646\u201351. https:\/\/doi.org\/10.1016\/j.breast.2012.01.014.","journal-title":"Breast."},{"issue":"6","key":"8494_CR3","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.breast.2010.05.014","volume":"19","author":"R S\u00f8rum","year":"2010","unstructured":"S\u00f8rum R, Hofvind S, Skaane P, Haldorsen T. Trends in incidence of ductal carcinoma in situ: the effect of a population-based screening programme. Breast. 2010;19(6):499\u2013505. https:\/\/doi.org\/10.1016\/j.breast.2010.05.014.","journal-title":"Breast."},{"issue":"1","key":"8494_CR4","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s10549-008-0067-5","volume":"115","author":"LN van Steenbergen","year":"2009","unstructured":"van Steenbergen LN, Voogd AC, Roukema JA, Louwman WJ, Duijm LE, Coebergh JW, et al. Screening caused rising incidence rates of ductal carcinoma in situ of the breast. Breast Cancer Res Treat. 2009;115(1):181\u20133. https:\/\/doi.org\/10.1007\/s10549-008-0067-5.","journal-title":"Breast Cancer Res Treat"},{"issue":"21","key":"8494_CR5","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1056\/NEJMoa1206809","volume":"367","author":"A Bleyer","year":"2012","unstructured":"Bleyer A, Welch HG. Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med. 2012;367(21):1998\u20132005. https:\/\/doi.org\/10.1056\/NEJMoa1206809.","journal-title":"N Engl J Med"},{"issue":"1","key":"8494_CR6","doi-asserted-by":"publisher","first-page":"8882","DOI":"10.1038\/s41598-018-27152-3","volume":"8","author":"KS Choi","year":"2018","unstructured":"Choi KS, Yoon M, Song SH, Suh M, Park B, Jung KW, et al. Effect of mammography screening on stage at breast cancer diagnosis: results from the Korea National Cancer Screening Program. Sci Rep. 2018;8(1):8882. https:\/\/doi.org\/10.1038\/s41598-018-27152-3.","journal-title":"Sci Rep"},{"issue":"1","key":"8494_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4048\/jbc.2018.21.1.1","volume":"21","author":"SY Kang","year":"2018","unstructured":"Kang SY, Kim YS, Kim Z, Kim H-Y, Lee SK, Jung K-W, et al. Basic findings regarding breast Cancer in Korea in 2015: data from a breast Cancer registry. J Breast Cancer. 2018;21(1):1\u201310. https:\/\/doi.org\/10.4048\/jbc.2018.21.1.1.","journal-title":"J Breast Cancer"},{"issue":"5","key":"8494_CR8","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1097\/SLA.0000000000002239","volume":"267","author":"LE Elshof","year":"2018","unstructured":"Elshof LE, Schmidt MK, Rutgers EJT, van Leeuwen FE, Wesseling J, Schaapveld M. Cause-specific mortality in a population-based cohort of 9799 women treated for ductal carcinoma in situ. Ann Surg. 2018;267(5):952\u20138. https:\/\/doi.org\/10.1097\/SLA.0000000000002239.","journal-title":"Ann Surg"},{"issue":"7","key":"8494_CR9","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1001\/archinte.160.7.953","volume":"160","author":"VL Ernster","year":"2000","unstructured":"Ernster VL, Barclay J, Kerlikowske K, Wilkie H, Ballard-Barbash R. Mortality among women with ductal carcinoma in situ of the breast in the population-based surveillance, epidemiology and end results program. Arch Intern Med. 2000;160(7):953\u20138. https:\/\/doi.org\/10.1001\/archinte.160.7.953.","journal-title":"Arch Intern Med"},{"issue":"2","key":"8494_CR10","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s10549-014-3168-3","volume":"148","author":"A Berkman","year":"2014","unstructured":"Berkman A, F. Cole B, Ades PA, Dickey S, Higgins ST, Trentham-Dietz A, et al. Racial differences in breast cancer, cardiovascular disease, and all-cause mortality among women with ductal carcinoma in situ of the breast. Breast Cancer Res Treat. 2014;148(2):407\u201313. https:\/\/doi.org\/10.1007\/s10549-014-3168-3.","journal-title":"Breast Cancer Res Treat"},{"key":"8494_CR11","doi-asserted-by":"crossref","unstructured":"Boekel NB, Schaapveld M, Gietema JA, Rutgers EJ, Versteegh MI, Visser O, et al. Cardiovascular morbidity and mortality after treatment for ductal carcinoma in situ of the breast. J Natl Cancer Inst. 2014;106(8):dju156.","DOI":"10.1093\/jnci\/dju156"},{"issue":"11","key":"8494_CR12","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1002\/ijc.30413","volume":"140","author":"W He","year":"2017","unstructured":"He W, Sofie Lindstr\u00f6m L, Hall P, Czene K. Cause-specific mortality in women with breast cancer in situ. Int J Cancer. 2017;140(11):2414\u201321. https:\/\/doi.org\/10.1002\/ijc.30413.","journal-title":"Int J Cancer"},{"issue":"4","key":"8494_CR13","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1634\/theoncologist.2012-0376","volume":"18","author":"KJ Ruddy","year":"2013","unstructured":"Ruddy KJ, Meyer ME, Giobbie-Hurder A, Emmons KM, Weeks JC, Winer EP, et al. Long-term risk perceptions of women with ductal carcinoma in situ. Oncologist. 2013;18(4):362\u20138. https:\/\/doi.org\/10.1634\/theoncologist.2012-0376.","journal-title":"Oncologist."},{"issue":"4","key":"8494_CR14","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1093\/jnci\/djn010","volume":"100","author":"A Partridge","year":"2008","unstructured":"Partridge A, Adloff K, Blood E, Dees EC, Kaelin C, Golshan M, et al. Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: longitudinal results from a cohort study. J Natl Cancer Inst. 2008;100(4):243\u201351. https:\/\/doi.org\/10.1093\/jnci\/djn010.","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"8494_CR15","doi-asserted-by":"publisher","first-page":"71","DOI":"10.4332\/KJHPA.2016.26.1.71","volume":"26","author":"KH Kim","year":"2016","unstructured":"Kim KH. Comorbidity adjustment in health insurance claim database. Health Policy Manag. 2016;26(1):71\u20138. https:\/\/doi.org\/10.4332\/KJHPA.2016.26.1.71.","journal-title":"Health Policy Manag"},{"issue":"10","key":"8494_CR16","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/0895-4356(93)90103-8","volume":"46","author":"PS Romano","year":"1993","unstructured":"Romano PS, Roos LL, Jollis JG. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol. 1993;46(10):1075\u201390. https:\/\/doi.org\/10.1016\/0895-4356(93)90103-8.","journal-title":"J Clin Epidemiol"},{"issue":"7","key":"8494_CR17","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/s12094-018-1994-1","volume":"21","author":"A Roca-Barcelo","year":"2019","unstructured":"Roca-Barcelo A, Vinas G, Pla H, Carbo A, Comas R, Izquierdo A, et al. Mortality of women with ductal carcinoma in situ of the breast: a population-based study from the Girona province, Spain (1994-2013). Clin Transl Oncol. 2019;21(7):891\u20139. https:\/\/doi.org\/10.1007\/s12094-018-1994-1.","journal-title":"Clin Transl Oncol"},{"issue":"3","key":"8494_CR18","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1007\/s10549-011-1531-1","volume":"129","author":"RS Falk","year":"2011","unstructured":"Falk RS, Hofvind S, Skaane P, Haldorsen T. Second events following ductal carcinoma in situ of the breast: a register-based cohort study. Breast Cancer Res Treat. 2011;129(3):929\u201338. https:\/\/doi.org\/10.1007\/s10549-011-1531-1.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"8494_CR19","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s10549-018-4803-1","volume":"171","author":"C Wadsten","year":"2018","unstructured":"Wadsten C, Wennstig AK, Garmo H, Nilsson G, Blomqvist C, Holmberg L, et al. Risk of ischemic heart disease after radiotherapy for ductal carcinoma in situ. Breast Cancer Res Treat. 2018;171(1):95\u2013101. https:\/\/doi.org\/10.1007\/s10549-018-4803-1.","journal-title":"Breast Cancer Res Treat"},{"issue":"23","key":"8494_CR20","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1056\/NEJM199906103402306","volume":"340","author":"ME Mendelsohn","year":"1999","unstructured":"Mendelsohn ME, Karas RH. The protective effects of estrogen on the cardiovascular system. N Engl J Med. 1999;340(23):1801\u201311. https:\/\/doi.org\/10.1056\/NEJM199906103402306.","journal-title":"N Engl J Med"},{"issue":"5","key":"8494_CR21","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.ijrobp.2015.11.040","volume":"94","author":"NB Boekel","year":"2016","unstructured":"Boekel NB, Schaapveld M, Gietema JA, Russell NS, Poortmans P, Theuws JC, et al. Cardiovascular disease risk in a large, population-based cohort of breast Cancer survivors. Int J Radiat Oncol Biol Phys. 2016;94(5):1061\u201372. https:\/\/doi.org\/10.1016\/j.ijrobp.2015.11.040.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"8494_CR22","doi-asserted-by":"publisher","first-page":"5172","DOI":"10.1038\/s41467-019-13120-6","volume":"10","author":"NG Zaorsky","year":"2019","unstructured":"Zaorsky NG, Zhang Y, Tchelebi LT, Mackley HB, Chinchilli VM, Zacharia BE. Stroke among cancer patients. Nat Commun. 2019;10(1):5172.","journal-title":"Nat Commun"},{"issue":"12","key":"8494_CR23","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1016\/j.ejca.2012.01.005","volume":"48","author":"B Z\u00f6ller","year":"2012","unstructured":"Z\u00f6ller B, Ji J, Sundquist J, Sundquist K. Risk of haemorrhagic and ischaemic stroke in patients with cancer: a nationwide follow-up study from Sweden. Eur J Cancer. 2012;48(12):1875\u201383. https:\/\/doi.org\/10.1016\/j.ejca.2012.01.005.","journal-title":"Eur J Cancer"},{"issue":"3","key":"8494_CR24","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.ejca.2004.11.013","volume":"41","author":"G Nilsson","year":"2005","unstructured":"Nilsson G, Holmberg L, Garmo H, Terent A, Blomqvist C. Increased incidence of stroke in women with breast cancer. Eur J Cancer. 2005;41(3):423\u20139. https:\/\/doi.org\/10.1016\/j.ejca.2004.11.013.","journal-title":"Eur J Cancer"},{"issue":"2","key":"8494_CR25","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/ana.24325","volume":"77","author":"BB Navi","year":"2015","unstructured":"Navi BB, Reiner AS, Kamel H, Iadecola C, Elkind MS, Panageas KS, et al. Association between incident cancer and subsequent stroke. Ann Neurol. 2015;77(2):291\u2013300. https:\/\/doi.org\/10.1002\/ana.24325.","journal-title":"Ann Neurol"},{"issue":"18","key":"8494_CR26","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.1200\/JCO.2005.04.0014","volume":"24","author":"R Jagsi","year":"2006","unstructured":"Jagsi R, Griffith KA, Koelling T, Roberts R, Pierce LJ. Stroke rates and risk factors in patients treated with radiation therapy for early-stage breast cancer. J Clin Oncol. 2006;24(18):2779\u201385. https:\/\/doi.org\/10.1200\/JCO.2005.04.0014.","journal-title":"J Clin Oncol"},{"key":"8494_CR27","doi-asserted-by":"crossref","unstructured":"Yandrapalli S, Malik AH, Pemmasani G, Gupta K, Harikrishnan P, Nabors C, et al. Risk factors and outcomes during a first acute myocardial infarction in breast Cancer survivors compared with females without breast Cancer. Am J Med. 2020;133(4):444-51.","DOI":"10.1016\/j.amjmed.2019.10.018"},{"key":"8494_CR28","doi-asserted-by":"crossref","unstructured":"The Coronary Drug Project Research Group. Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project. N Engl J Med. 1980;303(18):1038\u201341.","DOI":"10.1056\/NEJM198010303031804"},{"issue":"8714","key":"8494_CR29","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/0140-6736(90)92095-Y","volume":"336","author":"RI Horwitz","year":"1990","unstructured":"Horwitz RI, Viscoli CM, Berkman L, Donaldson RM, Horwitz SM, Murray CJ, et al. Treatment adherence and risk of death after a myocardial infarction. Lancet. 1990;336(8714):542\u20135. https:\/\/doi.org\/10.1016\/0140-6736(90)92095-Y.","journal-title":"Lancet."},{"issue":"9503","key":"8494_CR30","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1016\/S0140-6736(05)67887-7","volume":"366","author":"M Clarke","year":"2005","unstructured":"Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans V, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;366(9503):2087\u2013106. https:\/\/doi.org\/10.1016\/S0140-6736(05)67887-7.","journal-title":"Lancet."},{"issue":"11","key":"8494_CR31","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa1209825","volume":"368","author":"SC Darby","year":"2013","unstructured":"Darby SC, Ewertz M, McGale P, Bennet AM, Blom-Goldman U, Br\u00f8nnum D, et al. Risk of ischemic heart disease in women after radiotherapy for breast Cancer. N Engl J Med. 2013;368(11):987\u201398. https:\/\/doi.org\/10.1056\/NEJMoa1209825.","journal-title":"N Engl J Med"},{"issue":"2","key":"8494_CR32","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s10549-016-4045-z","volume":"161","author":"W Haque","year":"2017","unstructured":"Haque W, Verma V, Haque A, Butler EB, Teh BS. Trends in cardiac mortality in women with ductal carcinoma in situ. Breast Cancer Res Treat. 2017;161(2):345\u201351. https:\/\/doi.org\/10.1007\/s10549-016-4045-z.","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"8494_CR33","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000013925","volume":"98","author":"SW Lai","year":"2019","unstructured":"Lai SW, Lin CL, Liao KF. Association between tamoxifen use and acute myocardial infarction in women with breast cancer. Medicine (Baltimore). 2019;98(3):e13925. https:\/\/doi.org\/10.1097\/MD.0000000000013925.","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"8494_CR34","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1002\/cncr.20900","volume":"103","author":"BD Bradbury","year":"2005","unstructured":"Bradbury BD, Lash TL, Kaye JA, Jick SS. Tamoxifen-treated breast carcinoma patients and the risk of acute myocardial infarction and newly-diagnosed angina. Cancer. 2005;103(6):1114\u201321. https:\/\/doi.org\/10.1002\/cncr.20900.","journal-title":"Cancer."},{"issue":"9","key":"8494_CR35","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1038\/sj.bjc.6602562","volume":"92","author":"AM Geiger","year":"2005","unstructured":"Geiger AM, Chen W, Bernstein L. Myocardial infarction risk and tamoxifen therapy for breast cancer. Br J Cancer. 2005;92(9):1614\u201320. https:\/\/doi.org\/10.1038\/sj.bjc.6602562.","journal-title":"Br J Cancer"},{"issue":"7","key":"8494_CR36","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1212\/01.WNL.0000140491.54664.50","volume":"63","author":"CD Bushnell","year":"2004","unstructured":"Bushnell CD, Goldstein LB. Risk of ischemic stroke with tamoxifen treatment for breast cancer: a meta-analysis. Neurology. 2004;63(7):1230\u20133. https:\/\/doi.org\/10.1212\/01.WNL.0000140491.54664.50.","journal-title":"Neurology."},{"issue":"9206","key":"8494_CR37","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/S0140-6736(05)72466-1","volume":"355","author":"JJ Dignam","year":"2000","unstructured":"Dignam JJ, Fisher B. Occurrence of stroke with tamoxifen in NSABP B-24. Lancet. 2000;355(9206):848\u20139. https:\/\/doi.org\/10.1016\/S0140-6736(05)72466-1.","journal-title":"Lancet."},{"issue":"20","key":"8494_CR38","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1093\/jnci\/djh285","volume":"96","author":"AM Geiger","year":"2004","unstructured":"Geiger AM, Fischberg GM, Chen W, Bernstein L. Stroke risk and tamoxifen therapy for breast cancer. J Natl Cancer Inst. 2004;96(20):1528\u201336. https:\/\/doi.org\/10.1093\/jnci\/djh285.","journal-title":"J Natl Cancer Inst"},{"key":"8494_CR39","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3389\/fneur.2019.00052","volume":"10","author":"HS Jang","year":"2019","unstructured":"Jang HS, Choi J, Shin J, Chung JW, Bang OY, Kim GM, et al. The long-term effect of Cancer on incident stroke: a Nationwide population-based cohort study in Korea. Front Neurol. 2019;10:52. https:\/\/doi.org\/10.3389\/fneur.2019.00052.","journal-title":"Front Neurol"},{"issue":"8","key":"8494_CR40","doi-asserted-by":"publisher","first-page":"e445","DOI":"10.1016\/S1470-2045(17)30535-1","volume":"18","author":"BE Levis","year":"2017","unstructured":"Levis BE, Binkley PF, Shapiro CL. Cardiotoxic effects of anthracycline-based therapy: what is the evidence and what are the potential harms? Lancet Oncol. 2017;18(8):e445\u2013e56. https:\/\/doi.org\/10.1016\/S1470-2045(17)30535-1.","journal-title":"Lancet Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-08494-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-021-08494-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-08494-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T20:05:23Z","timestamp":1624737923000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-021-08494-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,26]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["8494"],"URL":"https:\/\/doi.org\/10.1186\/s12885-021-08494-0","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,26]]},"assertion":[{"value":"4 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This study was approved by the NHIS inquiry commission, and all data were provided after de-identification. This study was also approved by the Institutional Review Board of Seoul St. Mary\u2019s Hospital (IRB no. KC18ZESI0157) and the need to obtain informed consent was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All data were provided after de-identification. The Institutional Review Board of Seoul St. Mary\u2019s Hospital waived for informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"This study was performed using the database from the National Health Insurance System (NHIS-2020-1-096); the results do not necessarily represent the opinion of the National Health Insurance Corporation.The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"735"}}